RLAY
NASDAQ · Biotechnology
Relay Therapeutics Inc
$9.61
+0.17 (+1.80%)
Open$9.55
Previous Close$9.44
Day High$9.95
Day Low$9.54
52W High$9.54
52W Low$1.78
Volume—
Avg Volume2.16M
Market Cap1.54B
P/E Ratio—
EPS$-1.75
SectorBiotechnology
Analyst Ratings
Strong Buy
18 analysts
Price Target
+578.8% upside
Current
$9.61
$9.61
Target
$65.23
$65.23
$47.67
$65.23 avg
$99.61
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 12.36M | 8.30M | 220.69M |
| Net Income | -417,234,202 | -252,156,044 | 45.13M |
| Profit Margin | -3,374.7% | -3,206.0% | 20.5% |
| EBITDA | -453,401,089 | -289,236,526 | 96.01M |
| Free Cash Flow | — | — | 41.24M |
| Rev Growth | +48.9% | +48.9% | +11.7% |
| Debt/Equity | — | — | 0.55 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $207.18 | +0.96% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.93 | +1.58% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.26 | +0.11% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $454.97 | +1.42% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $749.47 | +1.05% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.70 | +6.70% | 139.7 | 43.84B |